BriaCell Therapeutics Corp - New (BCTX) EBITDA (2021 - 2026)
BriaCell Therapeutics Corp - New (BCTX) EBITDA from Oct 31, 2021 to Apr 30, 2026. The TTM BriaCell Therapeutics Corp - New (BCTX) EBITDA is -$32M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
BriaCell Therapeutics Corp - New (BCTX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -1.35% |
| 3 Years TTM | -3.88% |
| All Time TTM | +17.41% |
Annual EBITDA change of BriaCell Therapeutics Corp - New (BCTX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$14M | -47.07% |
| 2025 | -$27M | -18.49% |
| 2024 | -$33M | +63.84% |
| 2023 | -$20M | +32.94% |
| 2022 | -$15M | +119.40% |
| 2021 | -$6.96M | +77.55% |
| 2020 | -$3.92M | -16.77% |
| 2019 | -$4.71M | N/A |